Paramune
Phase 1Paramune focuses on novel molecular mechanisms to treat cancers and autoimmune diseases more effectively. Our targets arise from fundamental new discoveries that provide transformative insights into disease pathology. Our therapeutic molecules are rigorously engineered to engage the identified targets. To that end, we utilize a variety of next-generation biologic formats (such as monoclonal antibodies, bispecifics, engagers and antibody cocktails) to enable our therapeutic candidates to deliv...
About
Paramune focuses on novel molecular mechanisms to treat cancers and autoimmune diseases more effectively. Our targets arise from fundamental new discoveries that provide transformative insights into disease pathology. Our therapeutic molecules are rigorously engineered to engage the identified targets. To that end, we utilize a variety of next-generation biologic formats (such as monoclonal antibodies, bispecifics, engagers and antibody cocktails) to enable our therapeutic candidates to deliv...
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile